Soybean isoflavone treatment induces osteoblast differentiation and proliferation by regulating analysis of Wnt/β-catenin pathway

- Soybean isoflavones (SI) have anti-bone resorptive activity in vivo.
- Little is known about the cellular and molecular mechanisms of this effect.
- SI promoted osteoblast proliferation and differentiation.
- SI resulted in activation of the Wnt/β-catenin pathway.
- SI may be a useful remedy for the treatment of osteoporosis.

It has been reported that soybean isoflavones (SI) have anti-bone resorptive activity in vivo. However, little is known about the cellular and molecular mechanisms of this effect. In this study, we investigated the effects of SI on osteoblast differentiation and proliferation. Results showed that SI promoted osteoblast proliferation and differentiation which could be marked as the formation of hydroxyapatite crystals or extracellular matrix and increased ALP level. SI treatment markedly decreased RANKL levels and increased OPG levels in osteoblast cells. SI resulted in activation of the Wnt/β-catenin pathway. These results demonstrate that SI may be a useful remedy for the treatment of osteoporosis.